Impact of the Oral Microbiota on Relapse in HNSCC Patients

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06807034

Acronym

MICR-ORL

Enrollment

100

Registered

2025-02-04

Start date

2024-11-18

Completion date

2027-01-20

Last updated

2025-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and Neck Cancer

Brief summary

to characterise the impact of microbiota in radiotherapy efficacy

Interventions

OTHERbuccal swabs

buccal swabs for microbiota analysis before and after radiotherapy

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

PREVENTION

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* head and neck cancer

Exclusion criteria

Design outcomes

Primary

Measure	Time frame	Description
Microbiota	2 years	Analysis of buccal microbiota by 16SrRNA gene sequencing

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026